Welab´s services can support all bioanalytical needs from drug discovery to preclinical and clinical development. Quantitative sample analysis of new compounds or biomarkers in human and animal matrices (blood, plasma, serum, urine and tissues) is an important aspect during the process of Drug Discovery and Development.
A GLP (Good Laboratory Practice) validated bioanalytical method is needed to support all development studies (e.g. toxicology studies and human clinical trials) intended for regulatory submissions or consultancy purposes.
Welab is a GLP compliant laboratory. Our bioanalytical services can meet the GLP requirements depending on customer needs.